Diadema Partners »

Phathom Pharmaceuticals shares owned by Diadema Partners

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $607k 55k 11.11

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Invesco
BlackRock
Millennium Management
Carlyle
Vanguard Capital Management
NEA Management Company
683 Capital Management
Ensign Peak Advisors
Catalys Pacific
Jennifer Ranahan
State Street Corporation
Geode Capital Management
Daniel D. Thurber

View all funds holding Phathom Pharmaceuticals